LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | A443654 | 0.12 | uM | LJP6 | 72 | hr | 513 | 2023 | 10401 | 0.1946 | 0.1527 |
MCF7 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 584 | 4156 | 0.1405 | -0.2230 |
MCF 10A | A443654 | 0.04 | uM | LJP6 | 72 | hr | 513 | 4000 | 10401 | 0.3846 | 0.3527 |
BT-20 | A443654 | 0.37 | uM | LJP6 | 72 | hr | 1657 | 1495 | 5505 | 0.2716 | -0.0422 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 513 | 692 | 10401 | 0.0666 | 0.0181 |
Hs 578T | A443654 | 0.37 | uM | LJP6 | 72 | hr | 929 | 952 | 3228 | 0.2950 | 0.0100 |
BT-20 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1657 | 1142 | 5505 | 0.2075 | -0.1339 |
BT-20 | A443654 | 10.0 | uM | LJP6 | 72 | hr | 1657 | 652 | 5505 | 0.1185 | -0.2613 |
Hs 578T | A443654 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2096 | 3228 | 0.6494 | 0.5077 |
Hs 578T | A443654 | 0.12 | uM | LJP6 | 72 | hr | 929 | 1547 | 3228 | 0.4794 | 0.2690 |
MCF 10A | A443654 | 3.33 | uM | LJP6 | 72 | hr | 513 | 351 | 10401 | 0.0338 | -0.0164 |
MCF 10A | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 487 | 10401 | 0.0469 | -0.0026 |
MCF 10A | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 513 | 588 | 10401 | 0.0566 | 0.0076 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 929 | 2985 | 3228 | 0.9249 | 0.8946 |
Hs 578T | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 929 | 736 | 3228 | 0.2281 | -0.0839 |
MCF7 | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 1235 | 664 | 4156 | 0.1598 | -0.1955 |
MDA-MB-231 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 868 | 2549 | 3486 | 0.7313 | 0.6422 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3186 | 4156 | 0.7667 | 0.6681 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3069 | 3228 | 0.9509 | 0.9311 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2283 | 4156 | 0.5495 | 0.3589 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3002 | 3228 | 0.9301 | 0.9018 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 2740 | 3228 | 0.8488 | 0.7877 |
BT-20 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1657 | 4854 | 5505 | 0.8817 | 0.8307 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2830 | 4156 | 0.6811 | 0.5462 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2890 | 4156 | 0.6955 | 0.5667 |